Become an EMPEA Member Today

Emerging Europe (CEE/CIS)

Please find below a sampling of some of the latest EMPEA statistics, programs and content covering information on the CEE and CIS regions. For a more comprehensive listing, please search "CEE" or CIS" and customizable criteria in Advanced SearchScroll down for additional data and resources.


Inside Perspectives: An Interview with Michael Calvey of Baring Vostok

Michael Calvey, Founder and Senior Partner of Baring Vostok, shares his perspectives on the private equity landscape in Russia and the Commonwealth of Independent States (CIS), and discusses some memorable transactions throughout his career in the region. Baring Vostok is one of the oldest and largest private equity firms focusing on Russia and the CIS; it recently closed its fifth fund with US$1.5 billion in aggregate capital commitments, constituting the largest fund raised for the region to date. Read more »


 

Featured Brief

EMPEA Brief: European Bank Deleveraging - Opportunities and Challenges for EM PE investors

This EMPEA Brief explores the impact of European bank deleveraging on the emerging markets, with a view toward identifying the opportunities and challenges the process presents to PE investors. The article examines the drivers and scale of European bank deleveraging, and quantifies the impact of deleveraging across all emerging market regions

Source: EM PE Review, October 2012

Views from the Field

Taking Stock of 2012 and the Prospects for EM PE in 2013

As 2012 came to a close, EMPEA reached out to a number of the industry’s leading practitioners to solicit their reflections on the year gone by, and to glean insights on the prospects for emerging markets private equity in the year ahead. For the View from Russia, we turned to Michael Calvey, Founder and Senior Partner of Baring Vostok Capital Partners.

Source: EMPEA, December 2012


 

CEE & CIS Fundraising and Investment

Source: EMPEA
  Fundraising (US$m) Investment (US$m)

2012

4,903

2,093

2011

1,752

3,480

2010

1,192

2,398

2009

1,586

3,323

2008

5,559

6,344

2007

14,629

NA

 


 

Additional Resources

EMPEA Professional Development Webcast - Investment Spotlight: Emerging Europe
In this EMPEA Professional Development Webcast, our panel of industry experts discuss the current state of the market and the impact of the Eurozone crisis on the region; the effects of the crisis on fundraising, investment activity and deal flow, portfolio management and exits; and the changing Emerging Europe investment landscape and 2012 private equity outlook. Source: EMPEA,  March 2012

EMPEA Insight: Turkey
Turkey’s unique geographic location has long been one of its defining characteristics: a country positioned at the nexus of civilizations and trade routes. While its recent history has been one of macroeconomic volatility, today, Turkey is widely perceived as an island of stability standing between two regions facing immense challenges. Source: EMPEA 2012.

Impact Case Study: Platinum Bank (Ukraine)
In 2004, recognizing the potential of Ukraine’s under-penetrated mortgage market, private equity fund manager Horizon Capital founded Platinum Bank. After rapid growth and a successful merger, the bank doubled its assets and expanded its retail network. Through Horizon Capital’s active ownership, Platinum Bank successfully navigated the global financial crisis and transformed into one of Ukraine’s fastest growing diversified consumer lenders, with a 35% compound annual growth rate in its retail unsecured loan portfolio. Source: EMPEA 2012

Impact Case Study: Sanitas Group (Lithuania, Poland and broader Central and Eastern Europe)
Looking to raise capital to complete an acquisition, Sanitas Group, Lithuania’s largest drug producer, partnered with a private equity consortium led by CVCI Private Equity. Receiving a total investment of EUR50 million between 2006 and 2008, the company was able to complete its acquisition of Polish drug maker Jelfa, S.A., adding more than 100 formulations to Sanitas’s product offering and giving the company a significant presence in Poland, Russia and Ukraine. During Sanitas’s partnership with CVCI Private Equity, the company grew its headcount of skilled workers, improved its drug safety standards and increased its development of complex products for which patients had few affordable alternatives.  Source: EMPEA 2012

Better than Her Reputation? A Closer Look at Russia’s Private Equity Landscape
According to the annual EMPEA/Coller Capital Emerging Markets Private Equity Survey, Russia has ranked at the bottom of all emerging markets in terms of investment attractiveness for the past three years. However, market participants assert that global impressions of Russia are not aligned with reality. This article aims to address this perception gap by taking a closer look at Russia's private equity environment in the context of its macroeconomic fundamentals.  Source: EM PE Review, April 2011